-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Preferences and ease of use of preservative-free IOP-lowering eye drop containers: A comparison of two multi-dose bottles
Kai Kaarniranta and Auli Ropo
Case Report: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Personalized medicine: challenges in biomarker-related clinical trial design
Pei He
Clinical Trail Methodology: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation